Mvm Partners, LLC Opti Nose, Inc. Transaction History
Mvm Partners, LLC
- $91.7 Billion
- Q3 2024
A detailed history of Mvm Partners, LLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Mvm Partners, LLC holds 14,605,263 shares of OPTN stock, worth $5.55 Million. This represents 10.4% of its overall portfolio holdings.
Number of Shares
14,605,263
Previous 14,605,263
-0.0%
Holding current value
$5.55 Million
Previous $15 Billion
36.63%
% of portfolio
10.4%
Previous 15.07%
Shares
1 transactions
Others Institutions Holding OPTN
# of Institutions
62Shares Held
88.3MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT14.4MShares$5.46 Million0.57% of portfolio
-
Great Point Partners LLC Greenwich, CT12.9MShares$4.89 Million3.98% of portfolio
-
Stonepine Capital Management, LLC Bend, OR5.69MShares$2.16 Million2.41% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY5.6MShares$2.13 Million0.45% of portfolio
-
Black Rock Inc. New York, NY5.27MShares$2 Million0.0% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $31.6M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...